ClinicalTrials.gg
Sign In
RecruitingNCT06910865CRHEUpdated Apr 4, 2025

Study of the Radio-clinical Correlation of Endolymphatic Hydrops

An observational study in Endolymphatic Hydrops, sponsored by University Hospital, Strasbourg, France. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-04-04.

Sponsored by University Hospital, Strasbourg, France · Observational

From the registry’s dates

  • Primary completion was expected by Dec 2025, 10 months ago, but the record still lists the study as recruiting.
  • Started Jul 2024; still recruiting 2 years 3 months later.
Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
100
Ages
18 Years and older
Sex
All
01

Study summary

In patients presenting with symptoms of endolymphatic hydrops, signs of vestibular dilation are often found on MRI. Some patients present with these radiological signs without vestibular clinical signs, or signs other than those of hydrops. No study has yet investigated the radiological-clinical correlation of endolymphatic hydrops by selecting patients based on their imaging findings and then comparing them to the symptoms presented.

02

Conditions studied

  • Endolymphatic Hydrops

Keywords

  • Endolymphatic Hydrops
03

In context

Lead sponsor

University Hospital, Strasbourg, France is the lead sponsor of 994 studies on the registry; 353 are open to participants now.

Browse University Hospital, Strasbourg, France studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult subject (≥18 years) presenting vestibular dilation on MRI

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult subject (≥18 years)
  • Subject presenting vestibular dilation on MRI

Exclusion criteria

Exclusion Criteria:

  • Subjects who have expressed opposition to the reuse of their data for scientific research purposes.
  • Subjects under legal protection
  • Subjects under guardianship or curatorship
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
100 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Nystagmus observed on videonystagmoscopy

    Nystagmus observed on videonystagmoscopy: * Unidirectional or multidirectional * Direction * Exhaustible or not * Perceptible or not

    Time frame: Up to 1 year

07

Study locations

1 of 1 sites recruiting
  • Service d'ORL et de Chirurgie Cervico-faciale - CHU de Strasbourg - France
    Strasbourg, 67091, France
    • Christian DEBRY, MD, PhD · Contact · christian.debry@chru-strasbourg.fr · 33 3 88 12 76 44
    • Christian DEBRY, MD, PhD · Principal investigator
    • Claire THIBAULT, MD · Sub investigator
    • Idir DJENNAOUI, MD · Sub investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 4, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06910865
Lead sponsor
University Hospital, Strasbourg, France
Responsible party
Sponsor
First posted
Apr 4, 2025
Start date
Jul 19, 2024
Primary completion
Dec 19, 2025 (estimated)
Completion
Dec 19, 2025 (estimated)
Last update
Apr 4, 2025

Study contacts

Christian DEBRY, MD, PhD
Contact
christian.debry@chru-strasbourg.fr
33 3 88 12 76 44

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Endolymphatic Hydrops

Other studies from this sponsor

University Hospital, Strasbourg, France →

Start the discussion